All Comments by
- Keith A. Wesnes on Toulouse: Experimental Drug Sensitizes Receptor, Boosts Cognition
- John Hardy on Next-Generation Sequencing: Boldly Going Where No Geneticist...
- Paul Coleman on Neurodegenerative basis of age-related cognitive decline.
- Henrik Zetterberg on Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis.
- Torleif Hard on Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.
- Joel Ross on The AD8—Dementia Screen Ready for Prime Time?
- luisa Onstead on Peripheral Aβ Seeds CAA and Parenchymal Amyloidosis
- Suzanne Tyas on Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia.
- Lars Lannfelt on Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.
- Fuyuki Kametani on Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.
- Kiumars Lalezarzadeh on Anesthesia and Cognitive Decline: No Link in Longitudinal Study
- Ramona Jean Alexander on The AD8—Dementia Screen Ready for Prime Time?
- James Montgomery on The AD8—Dementia Screen Ready for Prime Time?
- Markus Britschgi on A gene expression pattern in blood for the early detection of Alzheimer's disease.
- Brian Freibaum on Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.